Vitality Works, Inc. 100 vegetarian Fenugreek Capsules- recalled due to pieces of a pen, USA
6 months ago
Recall notice
FDA announced the recall of 1,025 bottles of 100 vegetarian Fenugreek Capsules by Vitality Works, Inc due to foreign material: pieces of a pen (writing utensil). These products were distributed to 55 Retail customers, representing 284 individual stores. All customers are located within the United States. There
…
is no foreign distribution. There is no distribution to US Government agencies or departments. Distribution is by small parcel shipper (UPS, FedEx). Distribution Chain Notification Date: August 24, 2023.
The recalled products are 100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Bottle with White Polypropylene Cap. Product distributed under multiple brands. Lot 2023-06871 (Lot numbers are generated by our ERP system and use the 4-digit year followed by a 5-digit sequential number.) Expires: 07/2028 Bottom Code: FENUGRK PCAP 202306871 EXP 07/28
This recall was initiated on 8/22/2023 and its status is ongoing. Do not consume, sell, or distribute the recalled products.
In case you experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Source: www.accessdata.fda.gov
The recalled products are 100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Bottle with White Polypropylene Cap. Product distributed under multiple brands. Lot 2023-06871 (Lot numbers are generated by our ERP system and use the 4-digit year followed by a 5-digit sequential number.) Expires: 07/2028 Bottom Code: FENUGRK PCAP 202306871 EXP 07/28
This recall was initiated on 8/22/2023 and its status is ongoing. Do not consume, sell, or distribute the recalled products.
In case you experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Source: www.accessdata.fda.gov
303
